Interferon-γ suppresses the proliferation and migration of human placenta-derived mesenchmal stromal cells and enhances their ability to induce the generation of CD4+CXCR5+Foxp3+Treg subset.

[1]  Ming O. Li,et al.  Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection. , 2017, Cold Spring Harbor perspectives in biology.

[2]  A. Dietz,et al.  Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production , 2016, Stem Cell Research & Therapy.

[3]  Seok-Goo Cho,et al.  Enhanced immunoregulation of mesenchymal stem cells by IL-10-producing type 1 regulatory T cells in collagen-induced arthritis , 2016, Scientific Reports.

[4]  W. Shi,et al.  Immunomodulation by mesenchymal stem cells in treating human autoimmune disease-associated lung fibrosis , 2016, Stem Cell Research & Therapy.

[5]  G. Camussi,et al.  Human Liver Stem Cells Suppress T-Cell Proliferation, NK Activity, and Dendritic Cell Differentiation , 2016, Stem cells international.

[6]  D. Agrawal,et al.  Mesenchymal stem cells and cutaneous wound healing: novel methods to increase cell delivery and therapeutic efficacy , 2016, Stem Cell Research & Therapy.

[7]  A. Pourfathollah,et al.  Increasing proliferation of murine adipose tissue-derived mesenchymal stem cells by TNF-α plus IFN-γ , 2016, Immunopharmacology and immunotoxicology.

[8]  B. Kalionis,et al.  Phenotypic and Functional Characterization of Mesenchymal Stem/Multipotent Stromal Cells from Decidua Basalis of Human Term Placenta , 2016, Stem cells international.

[9]  G. Lal,et al.  IL-10 from marginal zone precursor B cells controls the differentiation of Th17, Tfh and Tfr cells in transplantation tolerance. , 2016, Immunology letters.

[10]  N. Fazilleau,et al.  Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells , 2016, Nature Communications.

[11]  X. Luan,et al.  Interferon-γ and tumor necrosis factor-α promote the ability of human placenta-derived mesenchymal stromal cells to express programmed death ligand-2 and induce the differentiation of CD4(+)interleukin-10(+) and CD8(+)interleukin-10(+)Treg subsets. , 2015, Cytotherapy.

[12]  G. Reyes-Terán,et al.  This information is current as in Chronic InfectionFHof T Macaques May Contribute to Accumulation Infected Rhesus − Immunodeficiency Virus ) in SimianFHFollicular Helper Cell ( T Decreased T Follicular Regulatory Cell / T , 2015 .

[13]  Sheng Xu,et al.  Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models , 2015, Cell transplantation.

[14]  N. Che,et al.  Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia , 2015, Lupus.

[15]  K. Moudgil,et al.  Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy , 2014, International journal of molecular sciences.

[16]  O. Hyrien,et al.  Mesenchymal Stromal Cells Support the Viability and Differentiation of Follicular Lymphoma-Infiltrating Follicular Helper T-Cells , 2014, PloS one.

[17]  Fei Liu,et al.  The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease. , 2014, Biomaterials.

[18]  A. Bakan,et al.  Towards a three-dimensional microfluidic liver platform for predicting drug efficacy and toxicity in humans , 2013, Stem Cell Research & Therapy.

[19]  M. Avanzini,et al.  Antineutrophil cytoplasmic antibody-associated renal vasculitis treated with autologous mesenchymal stromal cells: evaluation of the contribution of immune-mediated mechanisms. , 2013, Mayo Clinic proceedings.

[20]  F. Djouad,et al.  Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells , 2013, Stem Cell Research & Therapy.

[21]  Seok-Goo Cho,et al.  Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice , 2013, Annals of Hematology.

[22]  X. Luan,et al.  Human placenta-derived mesenchymal stem cells suppress T cell proliferation and support the culture expansion of cord blood CD34⁺ cells: a comparison with human bone marrow-derived mesenchymal stem cells. , 2013, Tissue & cell.

[23]  X. Luan,et al.  Expression and biological function of programmed death ligands in human placenta mesenchymal stem cells , 2013, Cell biology international.

[24]  Alexandra C. Chadwick,et al.  CD8+ Foxp3+ Regulatory T Cells Are Induced during Graft-versus-Host Disease and Mitigate Disease Severity , 2012, The Journal of Immunology.

[25]  A. Schanaider,et al.  Intraperitoneal but Not Intravenous Cryopreserved Mesenchymal Stromal Cells Home to the Inflamed Colon and Ameliorate Experimental Colitis , 2012, PloS one.

[26]  R. Cancedda,et al.  Mesenchymal stem cells induce functionally active T-regulatory lymphocytes in a paracrine fashion and ameliorate experimental autoimmune uveitis. , 2012, Investigative ophthalmology & visual science.

[27]  Tim F. Rayner,et al.  Foxp3+ follicular regulatory T cells control T follicular helper cells and the germinal center response , 2011, Nature Medicine.

[28]  F. Dazzi,et al.  The immunomodulatory properties of mesenchymal stem cells , 2011, Seminars in Immunopathology.

[29]  W. Weimar,et al.  Inflammatory conditions affect gene expression and function of human adipose tissue‐derived mesenchymal stem cells , 2010, Clinical and experimental immunology.

[30]  F. Carrión,et al.  Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients , 2010, Lupus.

[31]  R. Zhao,et al.  Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report. , 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[32]  T. Braciale,et al.  Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10 , 2009, Nature Medicine.

[33]  S. Setty,et al.  IFN‐γ activation of mesenchymal stem cells for treatment and prevention of graft versus host disease , 2008, European journal of immunology.

[34]  A. Teixeira-Carvalho,et al.  IL‐10 produced by CD4+ and CD8+ T cells emerge as a putative immunoregulatory mechanism to counterbalance the monocyte‐derived TNF‐α and guarantee asymptomatic clinical status during chronic HTLV‐I infection , 2007, Clinical and experimental immunology.

[35]  Sergio Romagnani,et al.  Role for Interferon‐γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells , 2006 .

[36]  D. Robinson,et al.  Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent , 2005, The Journal of experimental medicine.

[37]  H. Cantor,et al.  Regulatory T cells and autoimmune disease , 2005, Immunological reviews.

[38]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[39]  M. Mohammadnia-Afrouzi,et al.  The effect of transplanted human Wharton's jelly mesenchymal stem cells treated with IFN-γ on experimental autoimmune encephalomyelitis mice. , 2017, Cellular immunology.

[40]  Z. Han,et al.  Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation. , 2013, International immunopharmacology.

[41]  Zhaohui Zheng,et al.  Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis. , 2008, Rheumatology.